Increased Coinfection of Mycoplasma pneumoniae and Chlamydia pneumoniae Among COVID‐19‐Positive Kidney Transplant Recipients
Authors:
Open Access
Abstract
Background: Kidney transplant recipients (KTRs) are highly susceptible to infections due to chronic immunosuppression. During the COVID‐19 pandemic, their risk of atypical bacterial coinfections may have changed, but this impact remains unclear. This study aimed to assess Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) coinfection patterns in COVID‐19‐positive KTRs. Methods: We retrospectively analyzed hospitalized patients between December 2017 and January 2025 to assess winter‐month positivity rates of MP and CP. Department‐level associations with COVID‐19 status were examined, and a focused analysis of 228 KTRs compared demographic, clinical, and laboratory data between COVID‐19‐positive and ‐negative groups. Results: MP and CP‐positive detection rates declined during 2020–2021 but rebounded sharply in the winter of 2022, while other respiratory viruses showed no similar increases. An increased risk of coinfection was particularly associated with the Nephrology, Respiratory, and Emergency Departments, where COVID‐19‐positive patients had significantly higher MP/CP positivity rates. Within the Nephrology Department, KTRs represented the most vulnerable subgroup. Compared with COVID‐19‐negative KTRs, COVID‐19‐positive KTRs showed significantly higher rates of pneumonia on imaging (96.3% vs. 80.9%, p = 0.001), MP infection (37.0% vs. 11.6%, p < 0.001), and CP infection (29.6% vs. 8.8%, p < 0.001). Laboratory test results revealed marked immune impairments in COVID‐19‐positive KTRs, including lower leukocyte, lymphocyte, and monocyte counts, profound depletion of T lymphocyte subsets (CD3 + CD4 + , CD3 + CD8 + ), and reduced natural killer cell counts, while hepatic and renal function indices remained largely comparable. Conclusions: The winter rebound of MP and CP infections during the epidemic wave of the severe acute respiratory syndrome coronavirus 2 Omicron variant appeared most pronounced among KTRs, especially those with concurrent COVID‐19 infection. The elevated coinfection risk may be explained by combined impairments of adaptive and innate immunity rather than organ dysfunction. These findings underscore the need for heightened surveillance, early diagnostic testing, and tailored preventive strategies for transplant recipients and other high‐risk populations during and after COVID‐19 surges.Keywords
Funding Information
- National Natural Science Foundation of China (82102485)
This publication has 15 references indexed in Scilit:
- Cycles of Susceptibility: Immunity Debt Explains Altered Infectious Disease Dynamics Post-PandemicClinical Infectious Diseases, 2024
- How Immunocompromised Hosts Were Left Behind in the Quest to Control the COVID-19 PandemicClinical Infectious Diseases, 2024
- From “Immunity Debt” to “Immunity Theft”—How COVID-19 Might Be Tied to Recent Respiratory Disease SurgesJAMA, 2024
- The COVID-19 Pandemic Rages on for People Who Are ImmunocompromisedJAMA, 2022
- The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID-19 PatientsCritical Care Research and Practice, 2021
- Elevated α-Hydroxybutyrate Dehydrogenase as an Independent Prognostic Factor for Mortality in Hospitalized Patients with COVID-19ESC Heart Failure, 2020
- NK cells modulate T cell responses via interaction with dendritic cells in Chlamydophila pneumoniae infectionCellular Immunology, 2020
- COVID-19 in Immunocompromised Hosts: What We Know So FarClinical Infectious Diseases, 2020
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory FailureCell Host & Microbe, 2020
- Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised PatientsClinical Infectious Diseases, 2018